Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

A gauge of the U.S. equities that equally weights stocks in the S&P 500 index was clinging to a slight gain on Friday afternoon. The Invesco S&P 500 Equal Weight ETF was up 0.1% in afternoon trading, ...

Informatica shares are down 49% in the last 12 months, compared with the S&P 500 index's SPX gain of 22.4%. Shares of rival International Business Machines Corp. (IBM) are up 39.3% in the last 12 ...

The persistent rise in US equities is helping promote a view that the relationships of old for stocks and traditional measures for value-oriented investing strategies no longer apply.

Choreo LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 12.0% in the fourth quarter, ...

CBRE Group posted strong fourth-quarter earnings for 2024, surpassing analyst expectations and demonstrating solid segment performance.

AI is still a nascent part of Moody's business, but the early indicators point to success for company. That makes the stock a terrific opportunity to buy hand over fist. Investors with a long-run ...

FactSet’s private markets data strategy, the relationship between risk and performance on the buy side and fixed income track record ...

On Wednesday the Labor Department is expected to report that in January the consumer price index rose 2.9% from a year ago, ...